The 340B program is facing mounting pressures from possible 340B rebates, new drugmaker data demands, federal policy uncertainty and an [...] …
Trade Association
Leading hospital and drug industry advocates clashed over the 340B program’s direction during a recent Washington, D.C., health care panel [...] …
The American Hospital Association (AHA) on Monday asked federal regulators to “take any and all available enforcement action” to halt [...] …
Breaking News
HHS Signals Plans to Drop 340B Rebate Pilot Appeal, Reconsider Drugmaker Plan Approvals
In a major reversal, the federal government said Monday that it plans to drop its appeal of an order blocking [...] …
Newly released IRS tax filings have provided new details on the pharmaceutical industry’s vast funding network and the total revenue [...] …
A pivotal federal court hearing on Friday could decide whether the government’s controversial 340B rebate pilot launches next month as [...] …
The American Hospital Association (AHA) recently announced that its president and CEO, Rick Pollack, will retire by the end of [...] …
A major pharmaceutical industry trade group and four individual drugmakers are seeking to intervene in a high-stakes hospital lawsuit aimed [...] …
A major drug industry trade group on Monday filed the first federal lawsuit challenging New Mexico’s 340B contract pharmacy access [...] …
Most health-system pharmacy leaders expect broader 340B rebate models and more challenges from contract pharmacy and eligibility restrictions—but say their [...] …










